Skip to main content
. 2021 Oct 20;7(11):888. doi: 10.3390/jof7110888

Table 5.

Sensitivity of diagnostic assays in patients with disease confirmed by culture and/or histopathology with comparison between pulmonary and extrapulmonary disease.

All Pulmonary Disease Extrapulmonary Disease p-Value *
Blastomyces EIA 52.1 47.3 68.8 0.13
(40.7–63.3) (34.7–60.2) (44.4–85.8)
37/71 26/55 11/16
Blastomyces Immunodiffusion 39.6 36.1 52.6 0.19
(30.1–49.8) (26.0–47.7) (31.7–72.7)
36/91 26/72 10/19
Blastomyces Complement Fixation 22.9 17.9 42.9 0.31
(12.1–39.0) (7.9–35.6) (15.8–75.0)
8/35 5/28 3/7
Urine Blastomyces Antigen 80.8 87.8 54.6 0.03
(68.1–89.2) (74.5–94.7) (28.0–78.7)
42/52 36/41 6/11
Serum Blastomyces Antigen 64.3 66.7 60.0 1.00
(38.8–83.7) (35.4–87.9) (23.1–88.2)
9/14 6/9 3/5
Histoplasma Complement Fixation 17.9 17.9 None -
(7.9–35.6) (7.9–35.6)
5/28 5/28
Histoplasma Immunodiffusion 0/7 0/7 None -
Urine Histoplasma Antigen 58.8 58.6 60.0 1.00
(42.2–73.6) (40.7–74.5) (23.1–88.2)
20/34 17/29 3/5

EIA: enzyme immunoassay, BAL: bronchoalveolar lavage. * Comparison between sputum and lower respiratory tract specimens (tracheal secretions, bronchial washings, bronchoalveolar lavage fluid).